| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | 0.53 | 0.001 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.57 | 0.003 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.091 | 0.006 |